Balchem Corporation (BCPC)
Official siteBASIC MATERIALS • SPECIALTY CHEMICALS • NASDAQ
Market Cap: $5.52B
Last updated: Nov 17, 2026 at 11:04 AM ET
Balchem Corporation (BCPC) Financials: Revenue, Profit and Cash Flow
Balchem reported revenue of $1.04B for the fiscal year ended Dec 31, 2025, up 8.8% from the year before. That year, net income was $154.84M with a net margin of 14.9%, operating cash flow was $216.56M and free cash flow was $173.07M. The quarter ended Sep 30, 2026 had revenue of $290.66M and net income of $46.73M.
Revenue and Margins
The operating margin was 20.2% in the fiscal year ended Dec 2025, the highest of the 10 years shown. Over the 9 years to Dec 2025, revenue grew from $553.20M, a compound annual rate of 7.3%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $1.04B | +8.8% | 35.7% | 20.2% | 14.9% |
| Dec 2024 | $953.68M | +3.4% | 35.3% | 19.2% | 13.5% |
| Dec 2023 | $922.44M | -2.1% | 32.7% | 17.3% | 11.8% |
| Dec 2022 | $942.36M | +17.9% | 29.8% | 15.4% | 11.2% |
| Dec 2021 | $799.02M | +13.6% | 30.4% | 16.0% | 12.0% |
| Dec 2020 | $703.64M | +9.3% | 31.8% | 15.8% | 12.0% |
| Dec 2019 | $643.71M | 0.0% | 32.8% | 15.9% | 12.4% |
| Dec 2018 | $643.68M | +8.2% | 31.7% | 16.6% | 12.2% |
| Dec 2017 | $594.79M | +7.5% | 31.8% | 16.3% | 15.1% |
| Dec 2016 | $553.20M | N/A | 32.7% | 16.4% | 10.1% |
Income Statement
In the fiscal year ended Dec 2025, net income rose 20.5% from the year before. In the quarter ended Sep 2026, net income rose 16.0% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.04B | $953.68M | $922.44M | $942.36M | $799.02M | $703.64M | $643.71M | $643.68M | $594.79M | $553.20M |
| Cost of revenue | $666.53M | $617.48M | $620.38M | $661.91M | $555.85M | $479.75M | $432.34M | $439.43M | $405.78M | $372.34M |
| Gross profit | $370.63M | $336.21M | $302.06M | $280.45M | $243.17M | $223.90M | $211.37M | $204.25M | $189.01M | $180.86M |
| Research and development | $18.51M | $16.79M | $15.05M | $12.19M | $13.52M | $10.33M | $11.38M | $11.59M | $9.30M | $7.33M |
| Operating income | $209.33M | $182.91M | $159.19M | $145.19M | $127.50M | $111.15M | $102.55M | $107.10M | $96.90M | $90.84M |
| Net income | $154.84M | $128.47M | $108.54M | $105.37M | $96.10M | $84.62M | $79.67M | $78.57M | $90.07M | $55.97M |
| EBITDA | $254.94M | $230.95M | $214.81M | $195.87M | $176.57M | $162.14M | $148.30M | $151.31M | $140.40M | $136.39M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $290.66M | $284.00M | $270.71M | $263.62M | $267.56M | $255.47M | $250.52M | $240.00M | $239.94M | $234.08M | $239.66M | $228.70M |
| Gross profit | $105.71M | $103.68M | $101.08M | $93.90M | $95.45M | $93.11M | $88.17M | $86.34M | $85.36M | $82.99M | $81.51M | $74.99M |
| Operating income | $62.44M | $59.22M | $55.63M | $52.29M | $54.58M | $51.44M | $51.02M | $47.44M | $47.99M | $45.80M | $41.68M | $38.34M |
| Net income | $46.73M | $44.62M | $40.28M | $39.23M | $40.29M | $38.28M | $37.05M | $33.58M | $33.84M | $32.07M | $28.99M | $26.65M |
Balance Sheet
As of Dec 2025, total debt of $189.26M exceeded cash and equivalents by $114.69M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $1.69B | $1.58B | $1.60B | $1.62B | $1.20B | $1.17B | $1.16B | $981.36M | $963.64M | $948.63M |
| Current assets | $365.61M | $313.77M | $314.24M | $335.80M | $322.23M | $266.89M | $254.95M | $226.31M | $199.34M | $188.44M |
| Cash and equivalents | $74.57M | $49.52M | $64.45M | $66.56M | $103.24M | $84.57M | $65.67M | $54.27M | $40.42M | $38.64M |
| Total liabilities | $428.84M | $425.46M | $543.23M | $686.23M | $322.31M | $337.61M | $412.01M | $289.74M | $346.75M | $427.59M |
| Short-term debt | $3.82M | $3.33M | $4.22M | $4.02M | $2.36M | $2.34M | $2.48M | $0 | $35.00M | $35.00M |
| Long-term debt | $185.44M | $209.34M | $326.15M | $467.38M | $108.57M | $174.09M | $256.40M | $163.37M | $189.81M | $252.39M |
| Shareholder equity | $1.26B | $1.15B | $1.05B | $938.28M | $877.01M | $828.23M | $743.67M | $691.62M | $616.88M | $521.03M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $1.70B | $1.69B | $1.69B | $1.71B | $1.66B | $1.68B | $1.62B | $1.58B | $1.60B | $1.57B | $1.59B | $1.60B |
| Total liabilities | $376.80M | $384.63M | $408.63M | $450.15M | $363.17M | $410.33M | $408.85M | $425.46M | $419.72M | $462.60M | $509.91M | $543.23M |
| Cash and equivalents | $66.26M | $63.17M | $72.87M | $74.57M | $65.09M | $65.43M | $49.90M | $49.52M | $73.69M | $63.74M | $60.35M | $64.45M |
| Shareholder equity | $1.33B | $1.30B | $1.29B | $1.26B | $1.30B | $1.27B | $1.21B | $1.15B | $1.18B | $1.11B | $1.08B | $1.05B |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 79.9% of operating cash flow. Dividends and share repurchases together came to 78.5% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $216.56M | $182.00M | $183.76M | $138.54M | $160.51M | $150.49M | $124.46M | $118.70M | $110.62M | $107.61M |
| Capital expenditures | $43.49M | $35.66M | $37.89M | $49.95M | $37.36M | $33.83M | $28.41M | $19.72M | $28.12M | $23.03M |
| Free cash flow | $173.07M | $146.34M | $145.87M | $88.59M | $123.15M | $116.67M | $96.05M | $98.97M | $82.50M | $84.58M |
| Dividends paid | $28.29M | $25.58M | $22.87M | $20.71M | $18.72M | $16.70M | $15.13M | $13.43M | $12.07M | $10.72M |
| Share repurchases | $107.64M | $5.68M | $4.47M | $35.42M | $35.24M | $13.46M | $21.32M | $1.39M | $1.91M | $1.59M |
| Investing cash flow | -$43.89M | -$59.74M | -$34.81M | -$416.01M | -$35.30M | -$34.59M | -$156.22M | -$31.99M | -$42.70M | -$133.59M |
| Financing cash flow | -$152.81M | -$133.81M | -$153.32M | $246.68M | -$102.18M | -$101.16M | $43.38M | -$71.45M | -$68.63M | -$19.45M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $69.77M | $46.71M | $40.06M | $67.28M | $65.57M | $47.25M | $36.46M | $52.32M | $51.30M | $44.99M | $33.39M | $67.41M |
| Capital expenditures | $12.47M | $10.89M | $6.25M | $16.21M | $14.90M | $6.81M | $5.56M | $12.72M | $9.15M | $6.88M | $6.91M | $11.71M |
| Free cash flow | $57.30M | $35.83M | $33.81M | $51.06M | $50.67M | $40.44M | $30.90M | $39.59M | $42.15M | $38.11M | $26.48M | $55.69M |
Frequently Asked Questions About BCPC
What is Balchem's annual revenue?
Balchem reported revenue of $1.04B for the fiscal year ended Dec 31, 2025.
How fast is Balchem's revenue growing?
Revenue was up 8.8% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 3.2%.
Is Balchem profitable?
Yes. Balchem reported net income of $154.84M for the fiscal year ended Dec 31, 2025, with a net margin of 14.9%.
How much free cash flow does BCPC generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $216.56M minus capital expenditures of $43.49M produced free cash flow of $173.07M.
How much debt does Balchem have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $185.44M, short-term debt of $3.82M and cash and equivalents of $74.57M.
BCPC pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors